Arcturus Therapeutics Holdings Inc. announced the formation of its Vaccine Platform Scientific Advisory Board (SAB) comprised of world-leading experts in the fields of virology, infectious disease, vaccine development and public health. Arcturus’ new SAB members: Jeff Colyer, M.D., CEO of Virtus Consultants; former Governor of Kansas; Ooi Eng Eong, Ph.D., BMBS, FRCPath, Professor and Deputy Director of the Emerging Infectious Diseases Programme at the Duke-NUS Medical School; Frederick G. Hayden, M.D., FACP, Professor Emeritus of Clinical Virology and Medicine at Virginia University School of Medicine; Peter A. Patriarca, M.D., Principal of Immuno-Vax and Senior Affiliate Consultant with the Biologics Consulting Group; Robert T. Schooley, M.D., Professor of Medicine and Senior Director of International Initiatives at the University of California San Diego; and Jonathan Smith, Ph.D., Chief Scientific Officer at VLP Therapeutics.